Scholarlink

<p>Heterogeneity is an important feature of cognitive impairment in patients with Parkinson’s disease (PD), with emerging evidence linking insulin resistance to accelerated cognitive decline. Our investigation examined the relationship between the triglyceride-glucose (TyG) index-a marker of insulin resistance-and cognition and striatal dopamine transporter (DAT) alterations in PD through cross-sectional and longitudinal analyses. In the primary cohort, higher TyG correlated with lower Mini-Mental State Examination (MMSE) scores (<i>p</i> &lt; 0.001) and increased dementia risk (<i>p</i> = 0.014). Longitudinal analysis in the PPMI cohort showed higher baseline TyG predicted greater Montreal Cognitive Assessment (MoCA) decline (<i>p</i> = 0.019) and reduced DAT activity in caudate (<i>p</i> = 0.033) and putamen (<i>p</i> = 0.019) over 4 years.DAT activity in the caudate mediated 24.1% of the TyG index’s longitudinal effect on MoCA scores, while the TyG index mediated 16.9% of CSF GLP-1R’s effect. These results highlight the TyG index as a potential biomarker for identifying PD patients at higher risk of cognitive impairment.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Triglyceride-glucose index predicts cognitive decline and striatal dopamine deficiency in Parkinson disease in two cohorts

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月13日

查看全文
  • Huimin Cao,
  • Yuying Zhao,
  • Ziyi Chen,
  • Xiaoya Zou,
  • Xinyi Du,
  • Li Yi,
  • Yu Ai,
  • Hongzhou Zuo,
  • Oumei Cheng,
  • Julia Gallagher,
  • Alice S. Chen-Plotkin,
  • Nabila Dahodwala,
  • James F. Morley,
  • Andrew D. Siderowf,
  • Allison W. Willis,
  • Daniel Weintraub,
  • Eugenia Mamikonyan,
  • Sharon X. Xie,
  • Caroline Gochanour,
  • Chelsea Caspell-Garcia,
  • Christopher S. Coffey,
  • Roseanne D. Dobkin,
  • Dag Aarsland,
  • Roy N. Alcalay,
  • Matthew J. Barrett,
  • Lana M. Chahine,
  • Jamie L. Eberling,
  • Alberto J. Espay,
  • James B. Leverenz,
  • Irene Litvan,
  • Irene H. Richard,
  • Liana S. Rosenthal,
  • Tatyana Simuni,
  • Michele K. York

摘要

Heterogeneity is an important feature of cognitive impairment in patients with Parkinson’s disease (PD), with emerging evidence linking insulin resistance to accelerated cognitive decline. Our investigation examined the relationship between the triglyceride-glucose (TyG) index-a marker of insulin resistance-and cognition and striatal dopamine transporter (DAT) alterations in PD through cross-sectional and longitudinal analyses. In the primary cohort, higher TyG correlated with lower Mini-Mental State Examination (MMSE) scores (p < 0.001) and increased dementia risk (p = 0.014). Longitudinal analysis in the PPMI cohort showed higher baseline TyG predicted greater Montreal Cognitive Assessment (MoCA) decline (p = 0.019) and reduced DAT activity in caudate (p = 0.033) and putamen (p = 0.019) over 4 years.DAT activity in the caudate mediated 24.1% of the TyG index’s longitudinal effect on MoCA scores, while the TyG index mediated 16.9% of CSF GLP-1R’s effect. These results highlight the TyG index as a potential biomarker for identifying PD patients at higher risk of cognitive impairment.